Faces of courage and hope : 16 inspiring journeys of people living with chronic myeloid leukaemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783000469886
- Dimensions
-
17 x 23 cm
- Extent
-
139 S.
- Language
-
Englisch
- Notes
-
zahlr. Ill.
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
B. Spangemacher
- (when)
-
[2014]
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:23 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spangemacher, Bert
- Griffin, Kate
- Leukemia Patient Advocates Foundation
- B. Spangemacher
Time of origin
- [2014]
Other Objects (12)
Identification of CDX2 targets in acute myeloid leukaemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Generation and characterisation of acute myeloid leukaemia-reactive CD4+ T-cells and their potential to eliminate human leukaemia blasts in NSG mice
Generation and characterisation of acute myeloid leukaemia-reactive CD4 + T cells and their potential to eliminate human leukaemia blasts in NSG mice
Identification of CDX2 targets in acute myeloid leukaemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Generation and characterisation of acute myeloid leukaemia-reactive CD4+ T-cells and their potential to eliminate human leukaemia blasts in NSG mice
Generation and characterisation of acute myeloid leukaemia-reactive CD4 + T cells and their potential to eliminate human leukaemia blasts in NSG mice
Identification of CDX2 targets in acute myeloid leukaemia
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Generation and characterisation of acute myeloid leukaemia-reactive CD4+ T-cells and their potential to eliminate human leukaemia blasts in NSG mice